文献速递胸部肿瘤放疗放疗物理与技术

肺癌SBRT运动管理技术是否影响局部控制?腹压与主动呼吸控制比较的单中心经验

Does Motion Management Technique for Lung SBRT Influence Local Control? A Single Institutional Experience Comparing Abdominal Compression to Breath-Hold Technique.
PubMed 文献 · Pract Radiat Oncol · 2020-10-30

该单中心回顾性注册研究比较腹压(COMP)与主动呼吸控制(ABC)两种呼吸运动管理技术在肺癌立体定向体部放疗(SBRT)中的局部失败(LF)率。2003年10月至2014年7月共873例患者931个病灶,中位随访16.4个月,总体粗LF率9.9%。

要点

  • ABC与COMP的3年实际局部失败率分别为13.8%与16.5%。

核心结论

  • 肺癌SBRT后局部失败率总体不受运动控制方式影响,按肿瘤类型分层后亦无差异。
  • 中央型肿瘤使用ABC时局部失败可能相关,值得进一步研究。

研究设计与样本

  • 单中心回顾性研究,调查经机构审查委员会批准的前瞻性注册数据库。
  • 纳入2003年10月至2014年7月接受SBRT的原发性肺癌(PRIME)或寡转移(OLIGO)患者,随访至少6个月。
  • 共873例患者931个病灶,比较COMP与ABC两种运动管理方式的局部失败率。

主要发现

  • 总体粗局部失败率为9.9%。
  • ABC与COMP的3年实际局部失败率分别为13.8%与16.5%。
  • 按OLIGO/PRIME分层后,ABC与COMP均与局部失败无显著关联。

关键数值与推荐

  • 中位年龄73岁(范围37-97),女性455例(52.1%)。
  • 中位KPS 80(范围40-100),中位BMI 26.2(范围12.1-56.3)。
  • 中位肿瘤大小2.2 cm(范围0.7-10.0),中位PET SUVmax 7.5(范围0.8-59)。
  • 中央型病灶234个(25.4%),PRIME病灶830个(89.2%),OLIGO病灶101个(10.8%)。
  • 中位随访16.4个月,中位SBRT剂量为50 Gy分5次。

临床怎么用

  • 对于肺癌SBRT,ABC与COMP在局部控制方面未见显著差异,技术选择可综合考虑临床条件。
  • 中央型肿瘤采用ABC时需关注局部失败风险,可加强随访并进一步研究验证。
  • 肿瘤大小、PET SUVmax、BMI和中央型位置与局部失败相关,计划时应综合评估。

局限性

  • 单中心回顾性注册研究,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Abdominal compression (COMP) and breath-hold with an active breathing coordinator (ABC) device are 2 different respiratory motion management techniques used in lung stereotactic body radiation therapy (SBRT) practice. We compared local failure (LF) results for COMP versus ABC. METHODS AND MATERIALS: We surveyed our institutional review board-approved prospective registry for patients who were treated with SBRT for either a primary lung cancer (PRIME) or an oligometastatic (OLIGO) diagnosis with a minimum of 6 months' follow-up to determine their rates of local failure by motion management modality. RESULTS: From October 2003 to July 2014, 873 patients with 931 lesions were treated. Patient characteristics included: 455 (52.1%) female; median age of 73 years (range, 37-97); median Karnofsky performance status (KPS) of 80 (range, 40-100); and median BMI of 26.2 (range, 12.1-56.3). Tumor characteristics included: median tumor size of 2.2 cm (range, 0.7-10.0); median maximum standardized uptake value from positron emission tomography PET SUVmax of 7.5 (range, 0.8-59); 234 (25.4%) were central lesions; 830 (89.2%) lesions were PRIME; and 101 (10.8%) were OLIGO. Median follow-up and SBRT dose were 16.4 months and 50 G in 5 fractions, respectively. Overall crude rate of LF was 9.9%. Use of ABC was not associated with increased LF compared with COMP: hazard ratio (HR) = 1.043 (95% CI 0.48-2.29; P = .92). Three-year actuarial rates of LF for ABC versus COMP were 13.8% and 16.5%, respectively. After stratifying by OLIGO/PRIME, neither ABC nor COMP was significantly associated with LF. Central location may be associated with LF with ABC (HR = 2.087, P = .066). On univariate analysis, BMI, tumor size, PET SUV max and central location were associated with failure, with size the most significant. CONCLUSIONS: LF rates after lung SBRT were not influenced by form of motion control overall or when stratified by tumor type. Further study on LF rates for central tumors where ABC is used is warranted.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Gandhidasan S, Woody NM, Stephans KL, et al. Does Motion Management Technique for Lung SBRT Influence Local Control? A Single Institutional Experience Comparing Abdominal Compression to Breath-Hold Technique. Pract Radiat Oncol. 2020. PMID: 33130317. doi:10.1016/j.prro.2020.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。